Aprecia Pharmaceuticals and Cycle Pharmaceuticals Archives

Home Tags Aprecia Pharmaceuticals and Cycle Pharmaceuticals

Aprecia and Cycle will develop 3D printed orphan drugs

Yosra K. - December 14, 2017

Life-saving drugs for rare disease patients Aprecia Pharmaceuticals and Cycle Pharmaceuticals will collaborate to develop commercialize orphan drugs manufactured using 3D printing technology. Both companies...

About

Published by 3DA Solutions, 3D ADEPT Media is a trade press that tracks and analyses the latest trends in the additive manufacturing industry. As a source for high-quality, accurate, and timely additive manufacturing resources, we pride ourselves on delivering up-to-date information you can rely on through our online media and our print & interactive digital magazine 3D ADEPT Mag.

We love to think that this industry delivers “glocalized” manufacturing solutions to industries (in a nutshell, solutions that are both global and local). That is why we work with collaborators and partners across the world so that industries can easily identify the manufacturing path that best fits their needs. Learn more

CONTACT US : 3D ADEPT S.P.R.L (3DA)- VAT: BE0681.599.796
Rue Borrens 51 – 1050 Brussels
Email: contact@3dadept.com
Tel: +32(0)486745887

AMGTA issues research on sustainability of powder and wire additive feedstock

A new chapter for GE Additive begins, as Colibrium Additive

3D Systems receives FDA Clearance for 3D-Printed PEEK Cranial Implants

Meltio unveils new robotic DED metal 3D printer developed in collaboration with FANUC and Accufacture

3D Systems receives FDA Clearance for 3D-Printed PEEK Cranial Implants

GE Additive team returns to the Cincinnati Zoo, this time to create a metal 3D printed cast.

Download the 2024 March/April edition of 3D ADEPT Mag

Integrating Additive Manufacturing for superior suspension systems

The quest to avoid or minimize support structures in Additive Manufacturing

Can Additive Manufacturing (AM) deliver “faulty” implications for its “green” credentials? (Part 3)

Key areas of focus in the application of ESG by AM companies (Part 2)

AM Companies must get started on their ESG journey. Here is how. (Part 1)

The use of AI and 3D Printing in construction

Beyond LPBF: Honeywell on finding the right opportunity with Additive Manufacturing

Thermwood’s Cut Layer Additive is an Additive Manufacturing process that does not 3D print. CEO Ken Susnjara explains why.

Greg Morris, the AMUG “Innovations Award Winner” on his journey, the adoption of AM across industries and the future of Zeda

Ceramic 3D printing role in hydrogen production is more tangible. 3DCeram demonstrates it in the HyP3D project

Thermwood’s Cut Layer Additive is an Additive Manufacturing process that does not 3D print. CEO Ken Susnjara explains why.

Identifying defects in metal 3D printed parts can lead to up to 70% savings in production costs. Materialise explains how and why.

Farsoon discusses customer-centric Metal AM solutions and applications

Download the 2024 March/April edition of 3D ADEPT Mag

Rapid.Tech 3D : New features that will mark this 20th anniversary

Get your free ticket for Hannover Messe 2024 and connect with companies beyond the AM industry

Additive Talks | How to ensure a pragmatic use of AM across the digital supply chain?

Tag: Aprecia Pharmaceuticals and Cycle Pharmaceuticals

Aprecia and Cycle will develop 3D printed orphan drugs